期刊文献+

ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍分析 被引量:4

原文传递
导出
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第18期1289-1292,共4页 National Medical Journal of China
基金 天津市科技发展计划基金资助项目(05YFSZSF02400 043803111)
  • 相关文献

参考文献9

  • 1何祎,冯四洲,王玫,魏嘉璘,秦铁军,周征,翟文静,邱录贵,韩明哲.HLA相合同胞异基因造血干细胞移植治疗慢性粒细胞白血病第1次慢性期51例分析[J].中华血液学杂志,2005,26(7):389-392. 被引量:15
  • 2Thomas ED,Storb R,Clift RA,et al.Bone marrow transplantation.N Engl J Med,1975,292:832 -843,895 -902.
  • 3Przepiorka D,Weisdorf D,Martin P,et al.1994 Consensus Conference on Acute GVHD Grading.Bone Marrow Transplant,1995,15:825-828.
  • 4Lee JH,Lee KH,Kim S,et al.Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.Bone Marrow Transplant,2000,25:179-184.
  • 5Sniecinski I,Oien I,Petz LD,et al.Immunohematologic consequences of major ABO mismatched bone marrow transplantation.Transplantation,1988,45:530-534.
  • 6Bar BM,van Dijk BA,Schattenberg A,et al.Erythrocyte repopulation after major ABO-incompatible transplantation with lymphocyte depleted bone marrow.Bone Marrow Transplant,1995,16:793-799.
  • 7黄晓军,刘代红,许兰平,韩伟,江倩,陈育红,张耀臣,刘开彦,鲍立,陆道培.主要ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍[J].中华血液学杂志,2005,26(9):548-550. 被引量:26
  • 8Gmur JP,Burger J,Schaffner A,et al.Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation.Blood,1990,75:290-295.
  • 9Scholl S,Klink A,Mugge LO,et al.Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.Transfusion,2005,45:1676-1683.

二级参考文献14

  • 1Devergie A, Blaise D, Attal M, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood, 1995, 85: 2263-2268.
  • 2Kim I, Park S, Kim BK, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfancytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans. Clin Transplant, 2001,15: 167-172.
  • 3Koh LP, Hwang WY, Tan CH, et al. Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefits. Ann Hematol, 2004, 83:286-294.
  • 4Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood, 2002,100: 3877-3886.
  • 5Craddock C, Szydlo RM, Dazzi F, et al. CMV seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored GVHD prophylaxis. BrJ Haematol, 2001, 112: 228-236.
  • 6Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol, 1997, 15: 433-444.
  • 7Lee JH, Lee KH, Kim S, et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant, 2000, 25: 179-184.
  • 8Gmur JP, Burger J, Schaffner A, et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood, 1990, 75:290-295.
  • 9Wernet D, Mayer G. Isoagglutinins following ABO-incompatible bone marrow transplantation. Vox Sang, 1992, 62:176-179.
  • 10Sniecinske I, Oien L, Petz LD, et al. Immunohematologic problems arising from ABO-incompatibile bone marrow transplantation. Transplantation Proceedings, 1987,111: 4609-4611.

共引文献39

同被引文献34

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部